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by 100 ~M tolbutamide. These properties resemble those of ATP-
sensitive K-channels in other cells. A lower estimate of 104 channels 
per HIT-T15 cell is obtained from the single channel and whole cell 
conductances, which would be increased if the lower conductance in 
5 mmol/l K. were allowed for, suggesting that this ce11-line may be a 
promising source of material for channel purification. 
258. Muscle lipoprotein lipase activity is decreased by glucose and in-
sulin 
B. Kiens, H. Lithe11, K.J. Milanes and E.A. Richter. August Krogh In-
stitute, University of Copenhagen, Oenmark and Uppsala Universi-
ty, Sweden 
The effect of a physiological increase in plasma insulin concentra-
tion on musc1e lipoprotein lipase activity (LPLA), on leg exchange of 
glucose and on serum lipoproteins was investigated in healthy young 
overnight-fasted men. During euglycaemic hyperinsulinaemia (n = 7) 
at 40 mU/I, m-LPLA decreased from 30 mU/g w.w. to 19 (p <0.05). 
The decrease correlated c10sely (r= 0.97) with the increase in leg glu-
cose uptake, and basal m-LPLA correlated with the increase in leg 
glucose uptake (r=0.93). In the control subjects (n=7) receiving sa-
line in place of insulin and glucose, m-LPLA was not changed with 
time. Insulin decreased VLOL-triacylglycerols (TG) by 47%, LOL-
cholesterol (C) by 5% and HO~-C by 15%. As LDL-C decreased 
less than total HOL-C, LOL-C/HDL-C ratio increased (8%) with in-
sulin, whereas the control subjects remained unchanged. It is con-
c1uded that in contrast to the effect on adipose tissue, physiological 
concentmtions of insulin decrease m-LPLA in proportion to the ef-
fect of insulin on glucose uptake. Furthermore, basal m-LPLA is an 
indicator of musc1e insulin sensitivity. 
259. Long-term registration of RR intervals during the night improves 
diagnosis of autonomous neuropathy 
M. Kirmayer, K. Piwernetz, C. Bayer!, R. Renner, and K. O. Hepp. 
Diabetes center, Klinikum München-Bogenhausen, FRG 
Even if a11 current tests for the diagnosis of autonomous neuropathy 
(AN) are applied, there remains residual inaccuracy (unknown actu-
al status and patients' compliance). In 53 Type 1 (insulin-dependent) 
diabetic patients RR intervals have been registered automatically for 
1 min from 22.00 hours to 08.00 hours every 15 min. Both the mini-
mum (CVmin) and the maximum CV (CVmax) have been evaluated. 
Additiona11y the coemeient of variation of the RR intervals (CV) un-
der resting conditions (CVrest) and forced respiration (CVresp) have 
been determined. Significant correlations: 
1) CVrest = 0.67 + 1.34/CVmin (r=0.688, p < 0.001), 
2) CVresp=0.31 + 3.56/CVmin (r= 0.862, p <0.001), 
3) CVresp= 0.30 + 0.58/CVmax (r=0.771, p < 0.001). Since the slope 
in (1) is higher than expected, the study indicates that the determina-
tion of heartbeat variation in routine tests is markedly biased. Eq. (2) 
demonstrates a high predictability of CVresp by the objective mea-
sure CVmin. Only pronounced stages of AN are diagnosed correctly 
by measuring CVrest and CVresp; intermediate stages are underesti-
mated. 
260. lsoproterenol modulates insulin activation of insulin receptor 
kinase in intact rat adipocytes 
H. H. Klein 1, S. Matthaei2 and P. e. Scriba 1. [)epartments of Internal 
Medicine, Universities of 1 Lübeck and 2Hamburg, FRG 
It has been shown that B-adrenergic agonists produce insulin resis-
tance both in vivo and in vitro. We studied whether this effect might 
be related to an ability of isoproterenol to alter the activation 01' insu-
lin receptor kinase (IRK) by insulin. Isolated rat adipocytes were 
preincubated for 30 min at 37°C wtih or without isoprotercnol. For 
activation of IRK, insulin (0-500 ng/ml) was then added and the 
cclls incubated for an additional 15 min. Insulin receptors were sub-
sequently isolated and immunoprecipitated in the presence of kinase 
and phosphatase inhibitors. IRK activity towards histone that was 
then measured in an assay with 0.5 ~molll 32p_ATP reflected the ac-
tivity state of the receptors while the ce11s were intact. Insulin incu-
bation of the cells resulted in a 20-30-fold increase in IRK activity. 
Compared to control ce11s, in cells pretrcated with isoproterenol, the 
insulin effect on IRK was decreased by 36.8 ± 3.3%, 37.3 ± 4.5%, 
27.8 ± 8.4%, and 9.6±8.3% at 1,4,20, and 500 ng/ml insulin, respec-
tively. In contrast, no alteration in 1251-insulin binding to ce11s pre-
treated with isoproterenol was observed (0.29 ± 0.05% and 0.28 ± 
0.04% per 105 cells at 0.2 ng/ml, in isoproterenol-treated and control 
cclls, respectively). Our data are consistent with the view that isopro-
terenol modulates the coupling of insulin binding to biological ac-
lions of insulin at or be fore the level of activation of IRK. 
Abstracts 
261. Strepto7-Otocin-induced Ia expression in pancreata and kidneys of 
mice 
C. Klinkhammer and H. Gleichmann. Diabetes Research Institute at 
the University of Düsseldorf, Düsseldorf, FRG 
It was assayed whether the expression of c1ass 11 molecules, i. e. Ia 
antigens, is effected by administration of the diabetogen streptozoto-
ein (STZ). BALB/c males received intraperitoneally either a single or 
multiple injections of STZ. Pancreata, kidneys, salivary glands and 
Iivers were removed at various time intervals after treatment and 
snapfrozen. Ia antigens were detected by a peroxidase-method on 
cryo-cut sections using a monoclonal antibody with specifieity for 
loAd. A monoc1onal antibody detecting Iak determinants was used 
for control. It was found that expression of Ia antigens was in-
creased in pancreatie, kidney and salivary gland tissues after a single 
injection of subdiabetogenic dosages of 10, 20, or 40 mg STZ/kg 
body weight or after 3 or 5 injections of 40 mg STZ/kg body weight. 
In contrast, in liver sections no increased la antigen expression was 
observed. Furthermore, a toxie dose of 200 mg STZ/kg body weight, 
inoculated once, resulted in la antigen expression in the islets only. 
Interestingly, the increa~ed c1ass 11 molecule expression was detect-
able already 6 h after STZ treatment. The kineties and dose-depen-
dency of the STZ-induced increment of Ia antigen expression will be 
presented, the significance related to the development of hypergly-
caemia discussed. 
262. Cholecystokinin-modulated phospholipid metaboIism and phos-
phoinositide breakdown in rat pancreatic isIets 
M. Klosa, H. P. T. Ammon and E.J. Verspohl. Oepartment of Pharma-
cology, Institute of Pharmaceutical Seiences, University ofTübingen, 
Tübingen, FRG 
The gut hormone cholecystokinin octapeptide (CCKs) sensitises the 
rat pancreatic B cell to glucose acting via specific ceK receptors. 
The relationship betwcen glucose- and CCK-induced insulin release 
and the phospholipid metabolism, phosphatidylinositol breakdown 
and emergence of inositol phosphates was investigated. When islets 
were labelIed with [3H]arachidonic acid for 90 min glucose decreased 
the incorporation of label into phosphoinositol and phosphatidyl-
serin (PI + PS), phosphatidy1choline (PC), phosphatidylethanol-
amine (PE) and diphosphatidylglycerol (OPG) in a dose-dependent 
manner. 10 nmol/l eCKs increased this glucose effect with respect 
to PC, PE and DPG. In myo-[3H] inositol prelabelled islets glucose 
in a dose-dependent manner increased inositol-l,4,5-triphosphate 
(IP3) without affecting inositol phosphate (IP) and inositol-l,4-bis-
phosphate (IP2). 10 nmolll eCKs dramatically incrcased IP3 and lP2 
and marginally IP, which was most prominent during the very first 
3 min. This eCK effect was most prominent at 3.0 and 8.3 mmolll 
glucose, but not 16.7 mmol/I. ce~ concomitantly decreased the 
source of inositolphosphates such as phosphatidylinositol 4,5-bis-
phosphate and phosphatidylinositol 4-phosphate. The data indicate 
a lower PC, PE and DPG labelling and a higher emergence of inosi-
tol phosphates probably from poly-phosphoinositides in rat pancre-
atic islet~ induced by ee~; this shift may be involved in the sensi-
tising effect of islets to glucose-mediated insulin release by ee~. 
263. In vitro non-activated mononuclear bIood cel1s produce factor(s) 
which increase unstimulated insulin release 
S. Knospe, E. Köhler, U. Fischer and D. Michaelis. Central Institute 
of Diabetes "Gerhardt Katsch", Karlsburg, GOR 
Glucose-stimulated insulin secretion from pancreatic islets is re-
duced by crude cc11-free supcrnatants of in vitro-activated (Iectins, 
antigens) peripheral blood mononuclear cells (MNC) from hcalthy 
donors. In this study, the effect of non-activated M NC on insulin re-
lease was compared with that of their cell-free culture supernatants. 
Insulin release from non-glucose stimulated islets was increased by 
the non-activated MNC from control subjccts (2.1 ± 1.4 vs 11.3 ± 
7.2 ng120 h per islet, n = 18, means ± SO) and from diabetic patients 
(2.2 ± 1.4 vs 11.3 ± 6.3 ng120 h per islet, n = 24). Insulin release was 
also increased in a dose- and time-dependent manner by superna-
tants of these MNC. Maximum insulin release from 20 h incubated 
islets was al ready caused by cell-frce supernatants obtained after a 
preincubation of 1·2 h. The effccts could partially be blocked by 
epinephrine (3 l1mol/l) and propranolol (6 ~mol/I) but not by heat 
inactivation of the culture supernatants. Thus, the observed effect is 
apparently not due to an action of interleukin 1. The study supports 
the role of soluble factor(s) released by MNC independent of anti-
gens mediating anti-islet immune responses in interaction with insu-
lin secretion. 
